Insider Alert: An Insider Just Sold Cytek Biosciences Inc Shares

Author's Avatar
Apr 09, 2022
Article's Main Image

GuruFocus data shows that Wenbin Jiang, President and CEO of Cytek Biosciences Inc. ( CTKB), sold 20000 shares on April 22, 2007. 0C0000C6TM.png

Insiders selling shares can cause investors concern. This could indicate that insiders have become bearish about the shares of their company's stock. Investors should pay close attention to insiders' ability to determine the company's value. We will take a closer look at Cytek Biosciences Inc's insider sale to determine if investors should be skeptical.

Wenbin Jiang trades

Wenbin Jiang sold total 40000 shares over the last year.

It means Wenbin Jiang is selling the stock of their company over a long term. Contrary to what one might expect, this could be a good sign for stock. Insiders selling frequently could indicate that their company has a large number of stock options for executives. Executives will sell some shares to raise cash. It is possible, however, that insiders became more bearish about the stock. Insider selling should not be taken lightly by investors.

Trends from the inside

One insider selling doesn't necessarily mean other insiders have a bearish view of the stock. Is the stock being sold by other insiders? Or have top company executives and owners bought more recently?

Cytek Biosciences Inc's insider transactions history shows that there were 11 insider buys over the last year. During the same period, 5 insider sales were also recorded.

Since this is a sign of a positive trend, we like to see insiders buying more than they sell. Investors may not be concerned if more insiders buy the stock than they sell it.

Please note, the numbers and facts quoted are as of the writing of this article and may not factor in the latest trading data or company announcements.

Want to provide feedback on this article? Have questions or concerns? Get in touch with us here, or email us at [email protected]!

This article is general in nature and does not represent the opinions of GuruFocus or any of its affiliates. This article is not intended to be financial advice, nor does it constitute investment advice or recommendations. It was written without regard to your individual situation or financial goals. We aim to bring you fundamental, data-driven analysis, The information on this site is in no way guaranteed for completeness, accuracy or in any other way.

0 / 5 (0 votes)
Author's Avatar

GuruFocus Screeners

Related Articles